Zymosense Secures $92,000 RuralSTAMINA Grant to Accelerate Phytase Commercialization

September 13, 2026

PRWeb USA

Overview

Zymosense, Inc. has been awarded a $92,000 commercialization grant through the NSF RuralSTAMINA Biomanufacturing Engine. This funding will be used to further advance the commercialization of its phytase enzyme. The grant marks a significant step in supporting the market introduction of phytase and strengthening Zymosense’s position in the biotechnology sector.

In Depth

Key Findings

Zymosense, Inc. has announced the receipt of a $92,000 commercialization grant from the National Science Foundation (NSF) through its RuralSTAMINA Biomanufacturing Engine program. This significant financial boost is specifically earmarked to accelerate the commercialization strategy for the company’s advanced phytase enzyme.

Technical / Clinical Details

Phytase is an enzyme critical for breaking down phytate, an anti-nutritional factor found in plant-based feedstuffs. In monogastric animals such as pigs and poultry, phytate binds to phosphorus, making it largely unavailable for digestion and leading to environmental pollution from excreted phosphorus. The addition of phytase to animal feed significantly improves phosphorus utilization efficiency, reducing the need for inorganic phosphate supplementation and mitigating environmental impact. Zymosense’s phytase is distinguished by its enhanced stability and activity across a broad range of feed formulations. The grant funds are expected to support the optimization of manufacturing processes, scale-up efforts, regulatory compliance, and the establishment of distribution channels necessary for market entry. Nanotechnology principles are being explored to further enhance the stability and delivery efficiency of such bio-products, potentially unlocking even greater performance benefits for Zymosense’s phytase.

Background & Industry Context

The global animal agriculture industry faces pressing challenges related to sustainable production and cost efficiency. Phytase, as a feed additive, is widely recognized as a key solution to these challenges, with its market size experiencing consistent growth. The NSF RuralSTAMINA program is designed to foster regional economic development and support the commercialization of innovative biotechnologies. Zymosense’s success in securing this grant underscores the perceived market value and technical superiority of its phytase technology. This development is particularly relevant in the context of nanotechnology’s growing role in enhancing the stability and delivery of enzyme-based products, pushing the boundaries of what is possible in bio-manufacturing.

Strategic Significance & Outlook

This grant provides Zymosense with a crucial springboard to accelerate phytase commercialization and bolster its competitive edge in the global market. The broader adoption of Zymosense’s phytase in various livestock applications promises not only economic benefits for the feed industry but also substantial environmental advantages by promoting sustainable animal husbandry practices. Looking ahead, the company aims to contribute to global food security and environmental conservation by providing more efficient and cost-effective phytase products.

Source: https://www.prweb.com/releases/business-technology-latest-news/nanotechnology-list/

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.